IRIS - Res&Arch Institutional Research Information System - Research & Archive

EUSEBI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.509
EU - Europa 3.710
AS - Asia 3.190
SA - Sud America 530
Continente sconosciuto - Info sul continente non disponibili 345
AF - Africa 82
OC - Oceania 6
Totale 13.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.320
SG - Singapore 1.482
IT - Italia 1.385
IE - Irlanda 558
CN - Cina 473
BR - Brasile 403
HK - Hong Kong 375
RU - Federazione Russa 360
VN - Vietnam 352
FR - Francia 263
DE - Germania 239
UA - Ucraina 195
FI - Finlandia 136
GB - Regno Unito 133
IN - India 110
SE - Svezia 102
CA - Canada 84
NL - Olanda 81
BD - Bangladesh 58
KR - Corea 55
TR - Turchia 50
IQ - Iraq 45
RO - Romania 41
AR - Argentina 40
MX - Messico 39
JP - Giappone 36
PL - Polonia 36
ES - Italia 30
AT - Austria 29
CH - Svizzera 27
ZA - Sudafrica 27
CO - Colombia 25
CZ - Repubblica Ceca 23
PK - Pakistan 20
ID - Indonesia 19
VE - Venezuela 19
SA - Arabia Saudita 17
UZ - Uzbekistan 17
BE - Belgio 15
LT - Lituania 15
EC - Ecuador 14
CL - Cile 13
JM - Giamaica 12
JO - Giordania 11
CR - Costa Rica 10
PH - Filippine 10
GR - Grecia 9
MA - Marocco 9
DZ - Algeria 8
AL - Albania 7
HN - Honduras 7
KE - Kenya 7
NI - Nicaragua 7
TN - Tunisia 7
KG - Kirghizistan 6
PY - Paraguay 6
AU - Australia 5
AZ - Azerbaigian 5
CI - Costa d'Avorio 5
ET - Etiopia 5
LB - Libano 5
MY - Malesia 5
NP - Nepal 5
PR - Porto Rico 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
DK - Danimarca 4
EG - Egitto 4
GT - Guatemala 4
IL - Israele 4
OM - Oman 4
PA - Panama 4
SI - Slovenia 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
EE - Estonia 3
GP - Guadalupe 3
HR - Croazia 3
SN - Senegal 3
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
EU - Europa 2
GA - Gabon 2
HU - Ungheria 2
KW - Kuwait 2
KZ - Kazakistan 2
PE - Perù 2
TH - Thailandia 2
TJ - Tagikistan 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DM - Dominica 1
Totale 13.011
Salva come PNG Salva come JPEG
Città #
Singapore 1.089
Chandler 650
Dublin 555
San Jose 512
Ashburn 439
Hong Kong 369
Perugia 302
San Mateo 258
Santa Clara 188
Boardman 182
Council Bluffs 180
Moscow 138
Altamura 135
Beijing 133
Wilmington 130
Dong Ket 121
Princeton 120
Medford 113
Lauterbourg 103
Munich 97
Lawrence 95
Jacksonville 91
Los Angeles 91
Milan 87
Des Moines 80
Ho Chi Minh City 78
Dallas 73
Rome 70
Andover 69
New York 69
Hanoi 56
The Dalles 56
Seoul 55
Ann Arbor 47
São Paulo 45
Helsinki 41
Atlanta 36
Chennai 36
Turku 35
Houston 33
Phoenix 33
Frankfurt am Main 32
Bucharest 30
Chicago 28
Tokyo 28
Orem 27
Brooklyn 26
Denver 26
Bologna 25
Norwalk 23
Poplar 23
Saint Petersburg 23
Izmir 22
Nuremberg 22
Montreal 21
Piscataway 21
Salerno 21
North Bergen 20
Warsaw 20
Carrboro 19
Falls Church 19
Genoa 19
Mexico City 19
Naples 19
Baghdad 18
Amsterdam 17
Verona 17
Seattle 16
Brussels 15
London 15
Modena 15
Stockholm 15
Brno 14
Falkenstein 14
Haiphong 14
Johannesburg 14
Redwood City 14
Toronto 14
Vienna 14
Boston 13
Buffalo 13
San Paolo di Civitate 13
Shanghai 13
Turin 13
Ankara 12
Dearborn 12
Manchester 12
Amman 11
San Francisco 11
Charlotte 10
Florence 10
Hefei 10
Kingston 10
New Delhi 10
Saint Louis 10
Tashkent 10
Catania 9
Columbus 9
Lausanne 9
Mumbai 9
Totale 8.078
Salva come PNG Salva come JPEG
Nome #
The validation of an Italian version of the Freezing of Gait Questionnaire 888
CSF and blood biomarkers for Parkinson's disease 218
Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study 170
A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria data-value project 170
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 169
Accuracy of ICD-9 codes in identifying patients with peptic ulcer and gastrointestinal hemorrhage in the regional healthcare administrative database of Umbria 163
Disturbi del comportamento alimentare nei maschi: l'importanza della distorsione dell'immagine corporea. 153
Validating malignant melanoma ICD-9-CM codes in Umbria, ASL Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study 153
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 153
Brain arteriovenous malformations and seizures: an Italian study. 150
Interatrial Shunting Through an Asymptomatic Patent Foramen Ovale in Thoracic Surgery 146
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 146
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 137
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 137
Validity of cerebrovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project 135
A magnetization transfer study of mild and advanced Parkinson's disease. 135
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 133
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 133
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 132
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 131
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 130
Applicazione della Scala Sulla Qualita della vita nelle residenze protette dell'Umbria 130
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 130
Dural arteriovenous fistulas and headache features: an observational study 130
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 130
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 129
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 128
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 127
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 126
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 126
Occipital arteriovenous malformations andmigraine. 125
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 125
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 124
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 124
Distorsione dell'immagine corporea nei DCA nei maschi 123
Multilevel Latent Class Models for evaluation of long term care facilities 122
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 122
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 121
The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up 121
Reliability and validity of the Italian versions of the Children's Fear Survey Schedule Dental Subscale and the Modified Child Dental Anxiety Scale 120
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. 119
Health technology disinvestment worldwide: Overview of programs and possible determinants 117
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 117
Oral health knowledge level of nursing staff working in semi-intensive heart failure units 117
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 117
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 116
Prevalence and risk of progression of preclinical Alzheimer's disease stages: A systematic review and meta-analysis 116
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 116
Stima della non autosufficienza negli anziani in Umbria 114
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment 114
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice 114
The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly 113
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine 112
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 112
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 111
Association between migraine and headache attributed to stroke: a case-control study. 111
Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease 111
Lysosomal enzyme activities in human brain 110
Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography–angiography 110
Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts 109
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 108
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 108
A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews 106
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 106
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 106
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 106
New pathological findings in an international cohort of hereditary spastic paraplegia 4 patients. 105
Protocol for validating cardiovascular and cerebrovascular ICD-9-CM codes in healthcare administrative databases: The Umbria Data Value Project 104
Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease 102
Underrecognition and undertreatment of dementia in Italian nursing homes. 99
Obsessive-compulsive disorder and migraine with medication-overuse headache. 97
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 96
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 96
Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases 96
Early management of patients with medication-overuse headache: results from a multicentre clinical study 94
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker 94
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 93
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 93
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 93
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: Protocol for a systematic review and meta-analysis 92
Parkinson's and Lewy body dementia CSF biomarkers 92
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 91
Stopping onabotulinum treatment after the first two cycles might not be justified: Results of a real-life monocentric prospective study in chronic migraine 91
Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment 91
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression 91
Drug-dependence behaviour and outcome of medication-overuse headache after treatment 90
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 90
Subclinical vestibular dysfunction in migraineurs without vertigo: A Clinical study 87
Misure relative all'obiettivo di salute numero uno del PSR 2003-2005: aspettativa di vita con e senza disabilità nella popolazione umbra. Anni 1999-2000 e 2004-2005 86
Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases 86
Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events? 86
Hyposmia correlates with axial signs and gait disorder in Parkinson's disease: an Italian Olfactory Identification Test study 85
Degradation of endocannabinoids in chronic migraine and medication overuse headache. 85
Condizioni di salute della popolazione anziana in Umbria negli anni 2004-2005 85
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 84
The possible role of Optical Coherence Tomography (OCT) and OCT‐Angiography (OCTA) as new non‐invasive biomarkers of prodromal Alzheimer’s disease 83
Le condizioni di salute della popolazione anziana 82
Multilevel Latent Class Models for evaluation of long term care facilities 81
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease 81
Stima della non autosufficienza negli anziani in Umbria 79
Totale 12.261
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.234
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022857 0 0 0 26 39 15 17 279 42 74 197 168
2022/20232.007 123 392 27 173 131 246 6 94 712 5 58 40
2023/2024884 40 82 39 28 18 21 197 38 42 42 150 187
2024/20252.038 48 142 82 132 211 151 111 179 369 124 318 171
2025/20264.414 274 279 245 544 654 410 661 251 542 371 111 72
2026/20271.304 122 194 332 656 0 0 0 0 0 0 0 0
Totale 13.372